Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
Pembrolizumab for Breast Cancer
Recruiting1 awardPhase 1
Montvale, New Jersey
"This trial will involve patients with advanced breast cancer who will receive either pembrolizumab with cryoablation or pembrolizumab alone. The treatment assignment will be random."
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.